Pharma DTC Spend Increasing At Twice The Rate Of Physician Promotions, GAO Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
A Government Accountability Office report, released Dec. 14, calls for improvements in FDA’s oversight of direct-to-consumer advertising.
You may also be interested in...
FDA Shows Limited Progress In Managing DTC Workload, GAO Tells House Panel
House Energy and Commerce panel hearing focuses on DTC ads for Vytorin, Lipitor and Procrit.
FDA Shows Limited Progress In Managing DTC Workload, GAO Tells House Panel
House Energy and Commerce panel hearing focuses on DTC ads for Vytorin, Lipitor and Procrit.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
The draft proposal is expected to be a stand-alone clause, not technically part of next year's reauthorization of the Prescription Drug User Fee Act.